Julian - Interview 33
Julian has prostate cancer. He is in a Phase 1 trial of a drug (a PARP inhibitor) which may stop cancer cells regrowing in people like him who have the BRCA2 genetic mutation. This mutation increases the risk of prostate and other cancers.
Julian is a research scientist and author, married, with 3 adult children. Ethnic background/nationality: White English Jewish.